Tenon Medical, Inc. TNON
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2022-04-27
Tenon Medical, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 59.8% | 52.2% | 42.4% | -92.8% | 65.6% |
| Operating margin | -324.3% | -420.1% | -537.1% | -2709.8% | -4038.1% |
| Net margin | -318.4% | -417.2% | -532.1% | -2737.6% | -4405.0% |
| FCF margin | -279.4% | -307.1% | -428.4% | -1862.8% | -2746.2% |
| Return on assets | -116.7% | -138.9% | -245.6% | -170.6% | -76.0% |
| Return on equity | -249.1% | -229.0% | -2002.7% | -302.6% | 34.3% |
| Current ratio | 2.11 | 4.39 | 1.24 | 3.69 | 0.50 |
| Revenue growth | 20.4% | 11.9% | 323.7% | 331.9% | — |
Source: SEC EDGAR filings · CIK 0001560293 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.